Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 16,806 | 11,792 | 11,338 | 7,295 | 4,619 |
| Operating Income | -16,806 | -11,792 | -11,338 | -7,295 | -4,619 |
| Interest Expense | 0 | 0 | 0 | -1 | 7 |
| Other Income | 1,002 | 945 | 930 | 1,027 | 665 |
| Pre-tax Income | -15,804 | -10,847 | -10,408 | -6,267 | -3,961 |
| Net Income Continuous | -15,804 | -10,847 | -10,408 | -6,267 | -3,961 |
| Net Income | $-15,804 | $-10,847 | $-10,408 | $-6,267 | $-3,961 |
| EPS Basic Total Ops | -0.40 | -0.27 | -0.28 | 3.99 | -0.19 |
| EPS Basic Continuous Ops | -0.40 | -0.27 | -0.28 | 3.98 | -0.19 |
| EPS Diluted Total Ops | -0.40 | -0.27 | -0.28 | 3.99 | -0.19 |
| EPS Diluted Continuous Ops | -0.40 | -0.27 | -0.28 | 3.98 | -0.19 |
| EPS Diluted Before Non-Recurring Items | -0.40 | -0.27 | -0.28 | -0.18 | -0.19 |
| EBITDA(a) | $-16,806 | $-11,792 | $-11,338 | $-7,295 | $-4,619 |